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Isoliquiritigenin (ISL), a natural antioxidant, has antitumor activity in different types of cancer cells.However the antitumor effect
of ISL on human tongue squamous carcinoma cells (TSCC) is not clear. Here we aimed to investigate the effects of synthetic
isoliquiritigenin (S-ISL) on TSCC and elucidate the underlying mechanisms. S-ISL was synthesized and elucidated from its nuclear
magnetic resonance spectrum and examined using high performance liquid chromatography. The effects of S-ISL on TSCC cells
(Tca8113) were evaluated in relation to cell proliferation, apoptosis and adhesion, migration, and invasion using sulforhodamine B
assay, fluorescence microscopy technique, flow cytometry (FCM) analysis, and Boyden chamber assay. The associated regulatory
mechanisms were examined using FCM and fluorescence microscopy for intracellular reactive oxygen species (ROS) generation,
Gelatin zymography assay for matrix metalloproteinase (MMP) activities, andWestern blot for apoptosis regulatory proteins (Bcl-
2 and Bax). Our data indicated that S-ISL inhibited Tca8113 cell proliferation, adhesion, migration, and invasion while promoting
the cell apoptosis. Such effects were accompanied by downregulation of Bcl-2 and upregulation of Bax, reduction of MMP-2 and
MMP-9 activities, and decreased ROS production. We conclude that S-ISL is a promising agent targeting TSCC through multiple
anticancer effects, regulated by its antioxidant mechanism.
1. Introduction
Squamous cell carcinoma of the tongue (TSCC) is one of
the most common malignant tumors in the oral cavity
and accounted for approximately 30% of all oral cancers
in the United States in 2006 [1]. Moreover, its incidence
has increased over the past decades worldwide [2]. Despite
advances in chemotherapy, radiotherapy, and surgical ther-
apy, the clinical outcomes and overall survival rates of TSCC
have not been significantly improved over the last decades
with overall five-year survival rate of less than 50% [3].
The high morbidity and mortality of oral cancers are largely
due to rapid tumor growth, frequent tumor recurrence, and
metastasis. Therefore, it is important to identify and develop
novel agents which could simultaneously target abnormal
proliferation, apoptosis, invasion, and metastasis of tongue
cancer.
Isoliquiritigenin (ISL), 2󸀠, 4󸀠, 4󸀠-three hydroxychalcone
(molecular structure shown in Supplementary Figure a in
Supplementary Material available online at https://doi.org/
10.1155/2017/1379430), mainly presents in roots of licorice
and many other plants, foods, beverages, and tobaccos [4].
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ISL possesses a wide variety of potent biological and
pharmacological activities, including anti-inflammatory [5],
antivirus [6], antioxidative [5], antiaging [7], and antidiabetic
activities [8]. We previously showed that ISL could signif-
icantly reduce cardiac reactive oxygen species (ROS) level
during hypoxia/reoxygenation, rendering protection against
myocardial ischemic injury [9] and inhibiting the growth of
prostate cancer cells [10]. ISL is reported to have anticar-
cinogenic effects in both in vivo and in vitro experimental
models. In vivo studies revealed that ISL inhibited chemically
induced colonic tumorigenesis [11], skin papilloma formation
[12], and lung metastasis of murine renal carcinoma cells
[13]. In vitro studies showed that ISL had antiproliferation
activities in skin [14], pulmonary [13], breast [15], prostate
[10], and gastric cancer cells [16]. A recent study showed
that ISL induced human oral squamous cell carcinoma cell
cycle G2/M phase arrest, apoptosis, and DNA damage [17],
implying that ISL is a promising chemopreventive agent
against oral cancer. However the antitumor effect of ISL on
TSCC is not fully characterized. In the present study, we
aimed to further investigate antiproliferative, proapoptotic,
and antimetastatic effects of ISL on human tongue squamous
carcinoma cells and elucidate the underlying mechanisms.
Since natural ISL compound preparation is expensive with
poor extraction rates and particularly wastes or destroys
natural resources, we selected to observe antitumor effects
of chemically synthesized ISL (S-ISL) in the study, which
has great advantages in future preclinical development and
clinical use, for example, reducing production costs and
protecting licorice natural resources.
2. Materials and Methods
2.1. The Synthesis of S-ISL. S-ISL was synthesized and
elucidated from its nuclear magnetic resonance spectrum
(Supplementary Figure) as previously described [18]. The
mixture of ethanol (5.6mL), 2, 4-dihydroxyacetophenone (1,
6.8 g, 44.7mmol) and 4-hydroxybenzaldehyde (2, 5.6 g,
45.9mmol) was added to aqueous potassium hydroxide
(41.6mL, 60%w/w). The above suspension was heated at
100∘C for 1.5 h and then stored overnight at room temper-
ature. The reaction mixture was poured onto ice (100 g)
and acidified to pH 4 using cold hydrochloric acid. The
precipitated yellow solid was filtered, washed with water
(200mL), and air-dried to a yellow solid (3, 7.5 g, 65%). 1H
NMR (400MHz, (CD3) CO): 𝛿 6.37 (s, 1 H), 6.47 (d, J =
8.0Hz, 1H), 6.93 (d, J = 8.0Hz, 2H), 7.74∼7.86 (m, 4H),
8.13 (d, J = 8.0Hz, 1H), 9.00 (s, 1 H), 9.47 (s, 1 H), 13.65 (s,
1 H); 13C NMR (100MHz, (CD3) CO): 𝛿 103.85, 108.76,
114.61, 116.86, 118.37, 127.67, 131.88, 133.38, 145.24, 161.07, 165.61,
167.67, 192.93 (Supplementary Figures b and c). Finally the
purity of S-ISL was analyzed by high performance liquid
chromatography (HPLC) method [19] with a C18 column
(5 𝜇m,4.6× 250mm),mixture ofmethanol andwater (80 : 20,
v : v) with rate of 1.0mL/min, and detected at 370 nm. Each
sample solution (10 𝜇L) was injected into the analysis system
(Supplementary Figure e). The purity of S-ISL acquired was
more than 95% and used in the subsequent studies.
2.2. Cell Culture. For comparison of specificity and sen-
sitivity of S-ISL in carcinoma cells, we initially screened
human tongue squamous carcinoma Tca8113 cells, human
liver carcinoma HepG2 cells, and rat pheochromocytoma
PC12 cells obtained from Chinese Academy of Sciences
(Shanghai, China). The cells were grown in complete Dul-
becco’s modified Eagle’s medium (DMEM; Invitrogen, Gibco,
Grand Island, NY, USA) and supplemented with 10% heat-
inactivated fetal bovine serum at 37∘C in a humidified atmo-
sphere containing 95% air/5% CO2. Exponentially growing
cells were used for experiments. S-ISL was dissolved in
dimethylsulfoxide (DMSO) to make a 10mg/mL stock solu-
tion, which was further diluted to appropriate concentration
with culture medium before each experiment.
2.3. Cell Viability Analysis Using Sulforhodamine BAssay. The
effects of S-ISL on the viability of Tca8113, HepG2, and PC12
cells were determined using sulforhodamine B (SRB) assay
(Sigma) [20]. Tca8113 cells (3.5 × 104 cells/mL), HepG-2 cells
(7 × 104 cells/mL), and PC12 cells (7 × 104 cells/mL) were
seeded in 96-well plates and were separately treated with
various concentrations of S-ISL for 24 h, 48 h, and 72 h. The
optical density in each well was read using microplate reader
at 570 nm.The experiment was repeated at least three times.
2.4. Determination of Intracellular ROS Generation. Intra-
cellular ROS generation was evaluated using dichlorodihy-
drofluorescein diacetate (DCFH-DA) assay (Sigma, St Louis,
MO,USA), which is a specific probe for hydrogen peroxide to
form fluorescent dichlorofluorescein [9]. All groups were
added with stimulant H2O2 (100 𝜇M) except the vehicle
group (0.5% DMSO) prior to treatment with 10 𝜇M DCFH-
DA at 37∘C for 30min. After incubation, cells were immedi-
ately submitted to fluorescencemicroscopy or flow cytometry
and estimated using FL-1 channel.
2.5. Cell Cycle Analysis Using Flow Cytometry. Cell cycle
analysis was carried out using flow cytometry (FCM) [21].
After Tca8113 cells were treated as described above, the cells
were harvested and washed twice with ice-cold phosphate-
buffered saline (PBS) and fixed with precooled ethanol (70%
v/v) overnight. Subsequently the cells were stained with
propidium iodide in PBS added with RNase in the dark
at room temperature for 30min. The sample was read on
a Coulter Epics XL flow cytometry (Beckman-Coulter Inc,
Fullerton, CA, USA).
2.6. Apoptosis Detection with Double Dye Annexin V-FITC/PI
and 4󸀠, 6-Diamidino-2-Phenylindole Dihydrochloride (DAPI)
Staining. The double dye Annexin V-FITC/PI was used to
distinguish between living cells, early and late apoptotic
cells, and necrotic cells [22]. The cells were treated in the
same manner as the cell cycle analysis, except no cooled
70% ethanol was added. For FCM analysis, the cells were
stained with Annexin V-FITC/PI and detected by FCM
using Annexin V-FITC cell Apoptosis Detection Kit (Sigma)
according to manufacturer’s instructions.
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For fluorescence microscope examination, Tca8113 cells
treated with S-ISL as described above were washed with ice-
cold PBS twice, fixed with ethanol for 30min, and stained
with DAPI (0.1𝜇g/mL, 2min) at room temperature away
from light. The stained cells were photographed with a flu-
orescence microscope (Olympus, Japan) at excitation wave-
length of 480 nm and emission wavelength of 530 nm.
2.7. Western Blotting Analysis. The proteins in total cell
lysates were separated on a 10% sodium dodecyl sulphate
(SDS)-polyacrylamide gel electrophoresis and transferred
onto polyvinylidene fluoride membrane (Millipore, Bed-
ford, MA, USA). Membranes were blocked with 5% nonfat
milk in tris-buffered saline buffer (pH 7.4) containing 0.1%
Tween-20 for 1 h and subsequently incubated with pri-
mary antibodies (1 : 1000 dilution) against Bcl-2, Bax (Santa
Cruz Biotechnology, Texas, USA) and GAPDH (Proteintech,
Rosemont, USA) at 4∘C overnight. Immunoreactive bands
were detected using anti-rabbit horseradish peroxidase-
conjugated secondary antibodies (1 : 3000 dilution) (Bey-
otime Biotechnology, Jiangsu, China) and visualized using
LumiPico ECL Reagent (Beyotime Biotechnology). The
densities of immunoblotting bands were analyzed using a
scanning densitometer (model GS-800; Bio-Rad, Shanghai,
China) coupled with Bio-Rad personal computer analysis
software.
2.8. Assays for Adhesion, Migration, and Invasion. Cell-
matrix adhesion assay was carried out as described previ-
ously [23]. Briefly the 96-well plates were precoated with
0.04 𝜇g/𝜇L matrigel 50 𝜇L in triplicate overnight at 4∘C and
then washed with wash buffer (0.1% bovine serum albumin
in medium). S-ISL pretreated cells were seeded in the pre-
coated 96-well plates and incubated at 37∘C. After 2 hours,
nonadherent cells were washed away and attached cells were
counted (Image-plus) and photographed from six randomly
selected fields under an inverted microscope (Olympus, Bei-
jing, China). The cell migration assay in vitro was performed
by using a modified Boyden chamber (Millipore, Billerica,
MA, USA) inserted with polyethylene terephthalate filter
membrane containing 8 𝜇m pores in 24 well culture plates
[24]. For cell migration assay, Tca8113 cells (2 × 105 cells/mL)
in serum-free medium, with or without S-ISL, were seeded
in triplicate in the upper chamber. Complete medium was
placed in the lower wells.The culture plates were incubated at
37∘C in a 5% CO2 atmosphere. After incubation, the medium
in the upper chamber was removed and washed with PBS
twice. The cells remaining on the upper surface of the filter
membrane were removed with cotton swabs and the cells
on the opposite surface of the filter membrane were stained
with 0.1% crystal violet for 5min. The migrated cells were
subjected to microscopic examination as described for the
adhesion assay. For invasion assay, the whole process was the
same as migration assay except that Tca8113 cells were loaded
on presolidified matrigel.
2.9. Gelatin Zymography Assay. The activities of matrix
metalloproteinase (MMP)-2 and MMP-9 in the conditioned
medium were determined by Gelatin zymography assay [25].
Briefly, the serum-free medium was collected by centrifuga-
tion to remove cells and cell debris and subsequently loaded
under nonreducing sample buffer onto SDS-polyacrylamide
gel polymerized with 1% Gelatin (Sigma). Following elec-
trophoresis, the gel was washed twice with rinsing buffer at
room temperature for 1.5 h to remove SDS and then incubated
in a developing buffer at 37∘C overnight. Gels were stained
with 0.1% Coomassie Brilliant Blue R-250 and destained in
the same solution without dye. Gelatinase activity was
visualized as clear bands against the blue-stained Gelatin
background.
2.10. Statistical Analysis. Data were expressed as mean ±
SD of multiple separate experiments. Statistical comparisons
were performed using analysis of variance (ANOVA) fol-
lowed by Student-Newman-Keuls’ post hoc test for multiple
comparisons using the computer statistical package (SPSS
21.0 forWindow). Differences with 𝑃 < 0.05were considered
statistically significant.
3. Results
3.1. Effects of S-ISL on Proliferation of Tca8113, HepG2, and
PC12 Cells. The effects of S-ISL on the proliferation of
Tca8113, HepG2, and PC12 cells were analyzed using SRB
analysis. S-ISL markedly inhibited the proliferation of the
above cells (Figure 1(a)), particularly Tca8113 cells and the
IC50 values were 17.70 𝜇g/mL, 10.04 𝜇g/mL, and 9.67𝜇g/mL
after 24 h, 48 h, and 72 h treatment, respectively. HepG2 cells
displayed intermediate responses to S-ISL and the IC50 values
were 19.07 𝜇g/mL, 15.08 𝜇g/mL, and 14.95 𝜇g/mL, respec-
tively, after the same treatment time. However, PC12 cell line
was particularly resistant to S-ISL and the IC50 values were
38.13 𝜇g/mL, 30.94𝜇g/mL, and 26.85𝜇g/mL, respectively. As
the present study demonstrated that Tca8113 were the most
sensitive cells responding to S-ISL treatment, the subsequent
studies were then focused on observing the effects of S-ISL on
Tca8113.
3.2. Effects of S-ISL on Intracellular ROS Generation. ROS
production was measured in Tca8113 cells using DCFH-
DA by fluorescence microscopy and FCM. As shown in
Figure 2(a), when S-ISL was incubated with Tca8113 cells at
varied concentrations from 12.5∼50𝜇g/mL, relative to H2O2
treatment alone, S-ISL groups reduced the fluorescence
values by 2.7%, 9.3%, and 18.6%, respectively. Likewise, H2O2
increased ROS production by 48.7% as compared with the
vehicle group under FCM analysis (Figure 2(b)). Compared
with H2O2 treatment alone, pretreatment with S-ISL at
concentrations ranging from 12.5∼50 𝜇g/mL resulted in a
decrease of intracellular ROS production and inhibition rate
was 9.03%, 4.31%, and 26.22%, respectively. These results
indicated that S-ISL suppressed intracellular ROS production
of Tca8113 cells.
3.3. Effects of S-ISL on Cell Cycle in Tca8113 Cells. Compared
to the vehicle control, S-ISL (6.25∼12.5 𝜇g/mL) induced cell
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Figure 1: Effect of S-ISL on proliferation and cell cycle of cancer cells:The effects of S-ISL (3.125∼50 𝜇g/mL) on Tca8113, HepG2 and PC12 cells
were observed for 24 h, 48 h, and 72 h using SRB assay (a) and the effects of S-ISL (6.25∼50 𝜇g/mL) on Tca8113 cell cycle were observed using
FCM analysis (b). SRB results were expressed as the mean ± SD of three experiments with five replicates. S-ISL: synthetic isoliquiritigenin;
SRB: sulforhodamine B; OD: optical density; IC50: 50% growth inhibition concentration; FCM: flow cytometry.
∗
𝑃 < 0.05, ∗∗𝑃 < 0.01 versus
the vehicle group.
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Figure 2: Effects of S-ISL on intracellular ROS levels: all groups were added with stimulant H2O2 (100𝜇M) except the vehicle group. The
change of ROS levels in response to S-ISL (12.5∼50 𝜇g/mL) was examined usingDCFH-DA analysis (a) and FCM analysis (b). S-ISL: synthetic
isoliquiritigenin; ROS: reactive oxygen species; DCFH-DA: 2󸀠, 7󸀠- dichlorodihydrofluorescein diacetate; FCM: flow cytometry.
accumulation in S phase with a corresponding decrease in
G2 phase while S-ISL 25∼50𝜇g/mL markedly induced cell
accumulation in G1 phase with a corresponding decrease in
S phase (Figure 2(b)). Cell cycle studies indicated a biphasic
effect of S-ISL, with a lower-concentration accumulation of
the cells in the S phase and a higher-concentration in G1
phase.
3.4. Effects of S-ISL on Apoptosis in Tca8113 Cells. As shown
in Figure 2(b), a fraction of cells with hypodiploid DNA
content representing apoptosis can be detected using cell
cycle analysis. S-ISL (25∼50𝜇g/mL) increased the percentage
of sub-G1 DNA content in Tca8113 cells as compared with the
vehicle treated groups.
Further, apoptotic cells were identified by chromatin
morphology using DAPI. After 24 h and 48 h treatment,
S-ISL (6.25–50𝜇g/mL) induced chromatin condensation in
Tca8113 cells compared to the vehicle cells (Figure 3(a)). The
ratio of apoptotic cells to total cells was 0.2%, 6.2%, 10.4%,
and 16.3%, respectively, after 24 h treatment of S-ISL, and
the ratio for 48 h treatment was 1.6%, 12.3%, 14.6%, and
30.4%, respectively. The morphological characteristics of the
vehicle cells demonstrated good spreading and flattening
with no DAPI staining of nuclei (Figure 3(a)). On the other
hand, Tca8113 cells pretreated with S-ISL (6.25∼50𝜇g/mL)
for 24 h and 48 h displayed cell rounding, weak spreading,
shrinking, and retracting of cellular processes. S-ISL treat-
ment resulted in brighter stained nuclei of Tca8113 cells
with condensed chromatin forming crescent-shaped profiles
around the periphery of the nuclei.
In addition, the apoptosis-inducing effect of S-ISL was
evaluated by double staining with Annexin V-FITC/PI to
distinguish between living cells, early and late apoptotic cells,
and necrotic cells. As shown in Figure 3(b), whenTca8113 cells
were treated without S-ISL, 97.9% of cells were in a normal
condition. After the cells were incubated with S-ISL (6.25∼
50 𝜇g/mL) for 24 h, 39.3%, 29.2%, 15.9%, and 4.86% of cells
were in early phase of apoptosis whereas there were few cells
in the late apoptotic/necrotic stage. These results indicated
that S-ISL had a negative concentration-dependent effect on
Tca8113 cell apoptosis induction, especially in the early phase
of apoptosis.
3.5. Changes of Bax and Bcl-2 Protein Expressions in Response
to S-ISL Treatment. Western blotting assay was performed to
evaluate the change of apoptosis regulators (Bax and Bcl-2) in
response to S-ISL treatment (Figure 4). Relative to the vehicle
group, S-ISL incubation from 12.5∼100 𝜇g/mL significantly
decreased Bcl-2 protein expression and increased Bax protein
expression in Tca8113 cells.
3.6. Effects of S-ISL on Tca8113 Cells Adhesion, Migration,
and Invasion. Cell-matrix adhesion assay showed that S-ISL
treatment remarkably decreased adhesion abilities of Tca8113
cells on matrigel-coated surface. As shown in Figure 5(a),
when the concentrations of S-ISL varied from 6.25 𝜇g/mL to
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Figure 3: Effects of S-ISL on apoptosis: The effects of S-ISL (6.25∼50 𝜇g/mL) on Tca8113 cell apoptosis were examined using fluorescence
microscopy technique (a) and FCM analysis (b). Apoptosis cells with powerful fluorescence bodies of nuclear fragmentation were marked by
arrows. S-ISL: synthetic isoliquiritigenin; FCM: flow cytometry.
50𝜇g/mL, the inhibitory adhesion rates were 39.18%, 51.55%,
54.64%, and 64.95%, respectively (𝑃 < 0.05 compared with
the control group).
Further, the effect of S-ISL on the migration of Tca8113
cells was examined using Boyden chamber assay. As shown
in Figure 5(b), the number of Tca8113 cells passing through
the polycarbonate membrane in S-ISL pretreated groups was
significantly less than that in the vehicle group (𝑃 < 0.05).
The inhibitory migration rates of S-ISL from 6.25 𝜇g/mL
to 50 𝜇g/mL were 21.33%, 58.59%, 62.73%, and 79.30%,
respectively.
As shown in Figure 5(c), S-ISL from 6.25𝜇g/mL to 50𝜇g/
mL also significantly inhibited Tca8113 cells invasion com-
pared to the vehicle group (𝑃 < 0.05) and the inhibitory rates
were 28.29%, 51.05%, 51.33%, and 58.04%, respectively. These
results indicated that S-ISL inhibited the adhesion,migration,
and invasion abilities of Tca8113 cells in a concentration-
dependent manner.
3.7. Changes of MMP-2 and MMP-9 Activities in Response
to S-ISL. In order to explore the possible antimetastatic
mechanism of S-ISL in Tca8113 cells, the activities of MMP-
2 and MMP-9 were tested using Gelatin zymography assay.
S-ISL treatment (6.25∼50𝜇g/mL) showed a concentration-
dependent reduction in MMP-2 and MMP-9 activities. The
inhibitory rates of MMP-2 were 13.57%, 21.02%, 24.45%, and
38.09%, and those of MMP-9 were 13.03%, 14.01%, 17.53%,
44.76%, respectively (Figure 6).These results indicate that the
inhibition of MMP-2 and MMP-9 by S-ISL might play a key
role in invasion and metastasis of Tca8113 cells.
4. Discussion
Our study shows that S-ISL has multiple anticancer effects on
human tongue squamous carcinoma cells, including specific
and biphasic effects of inhibiting proliferation, inducing cell
apoptosis and impeding adhesion, migration, and invasion.
The anticancer effects are attributed to increased levels of
apoptotic Bax/Bcl-2 ratio and decreased activity of MMP-2
and MMP-9, which is likely to be mediated via antioxidant
mechanisms of S-ISL.
The intracellular level of ROS is generally elevated in
cancer cells, affecting all characteristics of cell behaviour,
including cell cycle progression and proliferation, cell sur-
vival, and apoptosis and metastasis [26]. Like its natural
counterpart, our data showed that S-ISL also had the same
antioxidant capacity, providing the rational basis for our
ongoing investigation of its antitumor effects.
Firstly we observed the effects of S-ISL on the prolifer-
ation of human tongue squamous carcinoma line Tca8113,
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Figure 4: Bax and Bcl-2 protein expression in response to S-ISL: Western blots illustrate protein abundance of Bax and Bcl-2 using
representative samples from each group above the graph. Graphs show Bax and Bcl-2 protein abundance normalized into GAPDH after
S-ISL (12.5∼100 𝜇g/mL) treatment. S-ISL: synthetic isoliquiritigenin. Values are Mean (SD). ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 versus the vehicle group.
in comparison with human liver carcinoma HepG2 cells
and rat pheochromocytoma PC12 cells. S-ISL inhibited the
growth of Tca8113, HepG2, and PC12 cells in a concentration-
and time-dependent manner. Amongst these cells, Tca8113
cells exhibited the strongest response to S-ISL treatment.The
inhibitory concentration of S-ISL observed was similar to the
reports using the natural ISL [10, 16]. These results suggest
that the effect of S-ISL against Tca8113 cells is specific and
provide a first glimpse of the types of cancer cells that may
benefit from such treatment. Further we revealed that the
inhibitory effect of S-ISL on Tca8113 growth was due to a
biphasic effect of S-ISL on Tca8113 cell cycle with a lower-
concentration accumulation in the S phase and a higher-
concentration in G1 phase. Such effect is apparently different
fromG2/Mphase arrest induced by ISL in human lung cancer
cell line A549 and human oral squamous cell carcinoma
[17, 27], confirming the specific effects of S-ISL on Tca8113
cells.
Under physiological development, cell proliferation and
apoptosis maintain proper balance. Compelling evidence
indicates that some oncogenic mutations disrupt apoptosis,
leading to tumor initiation, progression, or metastasis [28].
To test whether S-ISL could induce tumor cells apoptosis, we
employed a variety of techniques including flow cytometry,
DAPI staining, and double staining with Annexin V-FITC/PI
to observe cell apoptosis related changes. Our data showed
that S-ISL significantly increased the number of dead cells in
a dose- and time-dependent manner. However, the dose
dependent effects from both assays of DAPI staining and
Annexin V-FITC/PI are contradictory in that the low dose
of S-ISL showed strongest apoptosis-inducing effect using
Annexin V-FITC/PI method while DAPI staining demon-
strated a positive concentration-dependent effect of S-ISL on
Tca8113 cell apoptosis induction. We argue that the appar-
ent discrepancy is possibly attributed to different phases/
aspects of apoptosis examined and different regulatory
mechanisms of ISL in different concentrations. Annexin
V-FITC/PI is used to detect early phase of apoptosis by
probing phosphatidylserine translocated from the internal
part of the plasma membrane to the external portion of the
membrane. In contrast, DAPI staining is used to examine
the morphological changes to quantify the apoptotic cells
which are likely to happen in the late phase of apoptosis.Thus
the same concentration of S-ISL may have different effects
if examined in different phases of the apoptotic process.
Additionally, we cannot exclude the possibility that different
cell signalling pathways may be initiated to regulate the cell
death under different concentrations of ISL exposure, which
need further studies. In analyzing morphological character-
istics, Tca8113 cells pretreated with S-ISL had typical changes
including cell rounding, reduced spreading, shrinking and
retracting of cellular processes, and brighter stained nuclei
with condensed chromatin forming crescent-shaped profiles
around the periphery of the nuclei. All of these changes
indicated that S-ISL caused apoptosis of Tca8113 cells. One of
the major genes that regulate apoptosis is the Bcl-2 family,
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Figure 5: Effects of S-ISL on adhesion, migration, and invasion: The representative images were shown in regard to adhesion (a), migration
(b), and invasion (c) of Tca8113 cells in response to S-ISL (6.25∼50 𝜇g/mL) treatment using an inverted microscope. S-ISL: synthetic
isoliquiritigenin.
which plays a critical role in the mitochondrial pathway of
apoptosis as either promoters (e.g., Bax) or inhibitors (e.g.,
Bcl-2) of the cell death process [29]. Therefore, the alteration
of intracellular Bax andBcl-2 expression ratio can affectmito-
chondrial content release [30] and determine susceptibility to
apoptosis [31]. In agreementwith the previous studies [10, 32],
Tca8113 cells with S-ISL treatment had an increase of Bax
and a decrease of Bcl-2 protein expression and alteration of
proapoptotic Bax/antiapoptotic Bcl-2.We therefore conclude
that the mechanism that S-ISL promoted apoptosis may be
via changing the levels of the Bcl-2 family and the ratio of
Bax and Bcl-2.
The majority of cancer related deaths are caused by
metastases. Therefore, it is important to develop therapeutic
interventions specifically targeting the metastatic process.
The metastatic cascade includes a succession of six dis-
tinct steps: localized invasion, intravasation, translocation,
extravasation, micrometastasis, and colonization [33]. The
basic strategy of our interventions is aimed at disturbing
cancer cells’ adhesion,migration, and invasion abilities which
are basic steps of metastasis. In this study, S-ISL inhibited
Tca8113 cells adhesion, migration, and invasion abilities,
indicating that S-ISL is a potential antimetastasis drug. MMP
is regarded as a key player of tumor invasion and metastasis.
The proteolytic activity of MMP is able to degrade extra-
cellular matrix (ECM) proteins and subsequently induces
or enhances tumor survival, invasion, and metastasis [34].
ROS in cancer not only regulate the expression of MMPs,
but also inactivate their inhibitors TIMP (tissue inhibitor of
metalloproteinase) [26]. Indeed, Tca8113 cells treated with S-
ISL with antioxidant characteristic showed a concentration-
dependent reduction of MMP-2 and MMP-9 activities. Thus
anti-invasion and metastasis effects of S-ISL on Tca8113 are
likely to be achieved via inhibiting MMP activities.
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Figure 6: MMP-2 and MMP-9 activities in response to S-ISL: MMP-2 and MMP-9 proteolytic activities were measured in Tca8113 cells
pretreated with S-ISL (6.25∼100 𝜇g/mL) at various concentrations for 24 h using Gelatin zymography assay. S-ISL: synthetic isoliquiritigenin;
MMP: matrix metalloproteinase. Values are Mean (SD). ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 versus the vehicle group.
Finally S-ISL showed a concentration-dependentmanner
in promotion of apoptosis, inhibiting proliferation, adhesion,
migration, and invasion of Tca8113 cells, with an effective and
optimal concentration from 25 to 50 𝜇g/mL. Previously, Lee
and colleagues reported that plasma ISL concentration could
reach 4.16 ± 1.80mg/mL after 30min of administration of a
50mg/kg intravenous dose of ISL to rats [35]. A recent study
showed that intraperitoneal administration of 1mg/kg of ISL
significantly decreased tumor size and inhibited the viability
of cancer cells in xenograft mouse model without apparent
side effects on normal cells [36].Therefore the concentrations
of S-ISL used in this study are highly achievable in vivo,
further supporting its promise in clinical application.
5. Conclusions
In summary, our data showed that S-ISL had antiproliferative,
proapoptotic, and antimetastatic effects on human tongue
squamous carcinoma cells through its antioxidant mecha-
nism and potentially could be a therapeutic agent against
tongue cancer.
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